Age-related white matter lesions (leukoaraiosis): An update

Brain and Nerve

Volumn 65, Issue 7, 2013, Pages 789-799

  Miki, Yukio ^a   Sakamoto, Shinichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age related white matter changes; Leukoaraiosis; White matter hyperintensities; White matter lesions

Indexed keywords

AGING; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIFFUSION TENSOR IMAGING; FALLING; GAIT DISORDER; HYPERTENSION; LEUKOARAIOSIS; REVIEW; VOLUMETRY;

AGE FACTORS; BRAIN DISEASES; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; RISK FACTORS; TIME FACTORS;

EID: 84880445459     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, et al: Incidental findings on brain MRI in the general population. N Engl J Med 357: 1821-1828, 2007 (Pubitemid 350044802)
2. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, et al: Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39: 2712-2719, 2008
3. The LADIS Study Group; Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, et al: 2001-2011: a decade of the LADIS (Leukoaraiosis And Disability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 32: 577-588, 2011
4. Itasaka S, Miki Y, Tomimoto H, Kamei I, Tsutsui K: Appearance of leukoaraiosis may be attenuated with compression by a chronic subdural hematoma. Eur J Radiol 49: 193-197, 2004
5. Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, et al: Heterogeneity in age-related white matter changes. Acta Neuropathol 122: 171-185, 2011
6. PROSPER Study Group; van den Heuvel DM, Admiraal-Behloul F, ten Dam VH, Olofsen H, Bollen EL, et al: Different progression rates for deep white matter hyperintensities in elderly men and women. Neurology 63: 1699-1701, 2004
7. Fazekas F, Kleinert R, Offenbacher H, Payer F, Schmidt R, et al: The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 12: 915-921, 1991
8. Debette S and Markus HS: The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341: c3666, 2010
9. Grueter BE and Schulz UG: Age-related cerebral white matter disease (leukoaraiosis): a review. Postgrad Med J 88: 79-87, 2012
10. Brain Nerve 64: 1377-1387, 2012
11. Schmidt R, Lechner H, Fazekas F, Niederkorn K, Reinhart B, et al: Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology 13: 308-313, 1994 (Pubitemid 24263566)
12. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, et al: Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 69: 974-978, 2007 (Pubitemid 47366050)
13. No To Shinkei 55: 1027-1032, 2003
14. No To Shinkei 50: 821-826, 1998
15. Hénon H, Godefroy O, Lucas C, Pruvo JP, Leys D: Risk factors and leukoaraiosis in stroke patients. Acta Neurol Scand 94: 137-144, 1996 (Pubitemid 26308801)
16. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, et al: Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70: 9-14, 2001 (Pubitemid 32096113)
17. Longstreth WT Jr: Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. J Neural Transm Suppl 53: 9-16, 1998
18. Simoni M, Li L, Paul NL, Gruter BE, Schulz UG, et al: Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients: population-based study. Neurology 79: 1215-1222, 2012
19. No To Shinkei 57: 125-130, 2005
20. Grinberg LT, Thal DR: Vascular pathology in the aged human brain. Acta Neuropathol 119: 277-290, 2010
21. Miki Y, Grossman RI, Udupa JK, Wei L, Kolson DL, et al: Isolated U-fiber involvement in MS: preliminary observations. Neurology 50: 1301-1306, 1998 (Pubitemid 28240343)
22. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302, 2011
23. Udaka F, Sawada H and Kameyama M: White matter lesions and dementia: MRI-pathological correlation. Ann N Y Acad Sci 977: 411-415, 2002 (Pubitemid 35418183)
24. Marshall VG, Bradley WG Jr, Marshall CE, Bhoopat T, Rhodes RH: Deep white matter infarction: correlation of MR imaging and histopathologic findings. Radiology 167: 517-522, 1988
25. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, et al: Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43: 1683-1689, 1993 (Pubitemid 23307935)
26. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, et al: Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol 9: 559-566, 1988
27. Matsusue E, Sugihara S, Fujii S, Ohama E, Kinoshita T, et al: White matter changes in elderly people: MR-pathologic correlations. Magn Reson Med Sci 5: 99-104, 2006
28. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, et al: Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82: 126-135, 2011
29. Black S, Gao F and Bilbao J: Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 40: S48-S52, 2009
30. Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA: Apoptosis in leukoaraiosis lesions. J Neurol Sci 203-204: 169-171, 2002 (Pubitemid 35287395)
31. Chimowitz MI, Estes ML, Furlan AJ, Awad IA: Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 49: 747-752, 1992
32. Brun A: Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 5: 145-147, 1994
33. Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC: Subcortical ischaemic vascular dementia. Lancet Neurol 1: 426-436, 2002 (Pubitemid 37159153)
34. Moody DM, Brown WR, Challa VR, Anderson RL: Periventricular venous collagenosis: association with leukoaraiosis. Radiology 194: 469-476, 1995
35. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM: Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann N Y Acad Sci 826: 103-116, 1997 (Pubitemid 27478034)
36. Moody DM, Thore CR, Anstrom JA, Challa VR, Langefeld CD, et al: Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology 233: 883-890, 2004
37. Sasaki M, Hirai T, Taoka T, Higano S, Wakabayashi C, et al: Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: a multicenter observer performance study. Neuroradiology 50: 753-758, 2008
38. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE: White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37: 1391-1398, 2006 (Pubitemid 44305715)
39. Pantoni L: Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9: 689-701, 2010
40. Pantoni L and Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 28: 652-659, 1997 (Pubitemid 27118393)
41. Yamada K, Nagakane Y, Sasajima H, Nakagawa M, Mineura K, et al: Incidental acute infarcts identified on diffusion-weighted images: a university hospital-based study. AJNR Am J Neuroradiol 29: 937-940, 2008 (Pubitemid 351684970)
42. Gouw AA, van der Flier WM, Pantoni L, Inzitari D, Erkinjuntti T, et al: On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke 39: 3083-3085, 2008
43. Tomimoto H, Ihara M, Wakita H, Ohtani R, Lin JX, et al: Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol 106: 527-534, 2003 (Pubitemid 37441608)
44. Shibata M, Ohtani R, Ihara M, Tomimoto H: White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35: 2598-2603, 2004 (Pubitemid 39458424)
45. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H: Blood-brain barrier dysfunction in Binswanger's disease: an immunohistochemical study. Acta Neuropathol 95: 78-84, 1998 (Pubitemid 28075930)
46. Ueno M, Tomimoto H, Akiguchi I, Wakita H, Sakamoto H: Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 22: 97-104, 2002 (Pubitemid 34038388)
47. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, et al: Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 27: 2069-2074, 1996 (Pubitemid 26372583)
48. Wardlaw JM, Sandercock PA, Dennis MS, Starr J: Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34: 806-812, 2003
49. Topakian R, Barrick TR, Howe FA, Markus HS: Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 81: 192-197, 2010
50. Fernandez-Cadenas I, Mendioroz M, Domingues-Montanari S, Del Rio-Espinola A, Delgado P, et al: Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients. Eur J Neurol 18: 826-835, 2011
51. Farrall AJ, Wardlaw JM: Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis. Neurobiol Aging 30: 337-352, 2009
52. Pluta R, Januszewski S, Ulamek M: Ischemic blood-brain barrier and amyloid in white matter as etiological factors in leukoaraiosis. Acta Neurochir Suppl 102: 353-356, 2008
53. Ochi M, Furuyama M, Satoh H, Satoh A, Seto M, et al: Age-related white matter hyperintensities attenuated by compression from a chronic subdural hematoma: possible contribution of brain interstitial fluid to the formation of leukoaraiosis. Magn Reson Med Sci 8: 139-142, 2009
54. Gouw AA, van der Flier WM, van Straaten EC, Pantoni L, Bastos-Leite AJ, et al: Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 25: 247-253, 2008 (Pubitemid 351450428)
55. Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, et al: White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 39: 80-89, 1998 (Pubitemid 28069798)
56. Kapeller P, Barber R, Vermeulen RJ, Adèr H, Scheltens P, et al: Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34: 441-445, 2003 (Pubitemid 36210903)
57. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA, et al: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149: 351-356, 1987 (Pubitemid 17104996)
58. Miki Y, Grossman RI, Udupa JK, Wei L, Polanský M, et al: Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images-lack of correlation between changes in T2-lesion volume and clinical findings. Radiology 213: 395-399, 1999 (Pubitemid 29510584)
59. Miki Y, Grossman RI, Udupa JK, van Buchem MA, Wei L, et al: Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. Radiology 210: 769-774, 1999 (Pubitemid 29124040)
60. Admiraal-Behloul F, van den Heuvel DM, Olofsen H, van Osch MJ, van der Grond J, et al: Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 28: 607-617, 2005 (Pubitemid 41541964)
61. ten Dam VH, van den Heuvel DM, de Craen AJ, Bollen EL, Murray HM, et al: Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities. Radiology 243: 198-203, 2007 (Pubitemid 46579711)
62. Dyrby TB, Rostrup E, Baaré WF, van Straaten EC, Barkhof F, et al: Segmentation of age-related white matter changes in a clinical multi-center study. Neuroimage 41: 335-345, 2008
63. Beare R, Srikanth V, Chen J, Phan TG, Stapleton J, et al: Development and validation of morphological segmentation of age-related cerebral white matter hyperintensities. Neuroimage 47: 199-203, 2009
64. de Boer R, Vrooman HA, van der Lijn F, Vernooij MW, Ikram MA, et al: White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage 45: 1151-1161, 2009
65. Chutinet A, Biffi A, Kanakis A, Fitzpatrick KM, Furie KL, et al: Severity of leukoaraiosis in large vessel atherosclerotic disease. AJNR Am J Neuroradiol 33: 1591-1595, 2012
66. Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, et al: Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 36: 1207-1211, 2005 (Pubitemid 40798740)
67. Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind MS, et al: Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol 69: 251-256, 2012
68. Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, et al: Impact of age-related cerebral white matter changes on the transition to disability: the LADIS study: rationale, design and methodology. Neuroepidemiology 24: 51-62, 2005 (Pubitemid 39664108)
69. Ikram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, et al: The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol 26: 811-824, 2011
70. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, et al: Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 41: 600-606, 2010
71. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, et al: Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35: 1857-1861, 2004 (Pubitemid 38971865)
72. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, et al: Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 36: 56-61, 2005 (Pubitemid 40054175)
73. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, et al: White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 58: 610-616, 2005 (Pubitemid 41377225)
74. Buyck JF, Dufouil C, Mazoyer B, Maillard P, Ducimetière P, et al: Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke 40: 2327-2331, 2009
75. Arima H, Chalmers J: PROGRESS: Prevention of Recurrent Stroke. J Clin Hypertens (Greenwich) 13: 693-702, 2011
76. Shinohara Y, Tohgi H, Hirai S, Terashi A, Fukuuchi Y, et al: Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment. Cerebrovasc Dis 24: 202-209, 2007 (Pubitemid 47295584)
77. Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H: Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 39: 1607-1609, 2008
78. Rotterdam Scan Study; Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, et al: Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34: 1126-1129, 2003
79. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, et al: White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 35: 1821-1825, 2004 (Pubitemid 38971858)
80. Bokura H, Kobayashi S, Yamaguchi S, Iijima K, Nagai A, et al: Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 15: 57-63, 2006 (Pubitemid 43324967)
81. Fukuda H, Kitani M: Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 26: 1593-1597, 1995
82. Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser MG, et al: Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 112: 1644-1650, 2005 (Pubitemid 41324527)
83. Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, et al: Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke 40: 1269-1274, 2009
84. Bombois S, Debette S, Bruandet A, Delbeuck X, Delmaire C, et al: Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke 39: 2046-2051, 2008
85. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, et al: Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22: 13-22, 2003 (Pubitemid 36131969)
86. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, et al: Cerebral white matter lesions and the risk of dementia. Arch Neurol 61: 1531-1534, 2004 (Pubitemid 39350263)
87. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, et al: Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 65: 94-100, 2008
88. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, et al: Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 36: 2116-2120, 2005 (Pubitemid 41429230)
89. Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, et al: Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 38: 2924-2930, 2007 (Pubitemid 350041561)
90. Zheng JJ, Delbaere K, Close JC, Sachdev PS, Lord SR: Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review. Stroke 42: 2086-2090, 2011
91. O'Brien JT, Firbank MJ, Krishnan MS, van Straaten EC, van der Flier WM, et al: White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry 14: 834-841, 2006 (Pubitemid 44556477)
92. Krishnan MS, O'Brien JT, Firbank MJ, Pantoni L, Carlucci G, et al: Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry 21: 983-989, 2006 (Pubitemid 44596394)
93. O'Sullivan M: Leukoaraiosis. Pract Neurol 8: 26-38, 2008
94. Fujishima M, Yao H, Terashi A, Tagawa K, Matsumoto M, et al: Deep white matter lesions on MRI, and not silent brain infarcts are related to headache and dizziness of non-specific cause in non-stroke Japanese subjects. Intern Med 39: 727-731, 2000
95. Appelman AP, Vincken KL, van der Graaf Y, Vlek AL, Witkamp TD, et al: White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study. Cerebrovasc Dis 29: 28-35, 2010
96. Schmidt R, Grazer A, Enzinger C, Ropele S, Homayoon N, et al: MRI-detected white matter lesions: do they really matter? J Neural Transm 118: 673-681, 2011
97. Yamauchi H, Fukuyama H, Ogawa M, Ouchi Y, Kimura J: Callosal atrophy in patients with lacunar infarction and extensive leukoaraiosis: an indicator of cognitive impairment. Stroke 25: 1788-1793, 1994
98. Yamauchi H, Fukuyama H, Shio H: Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment. Stroke 31: 1515-1520, 2000
99. Tomimoto H, Lin JX, Matsuo A, Ihara M, Ohtani R, et al: Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia. J Neurol 251: 398-406, 2004 (Pubitemid 38501296)
100. Jokinen H, Ryberg C, Kalska H, Ylikoski R, Rostrup E, et al: Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study. J Neurol Neurosurg Psychiatry 78: 491-496, 2007 (Pubitemid 46662897)
101. Ryberg C, Rostrup E, Sjöstrand K, Paulson OB, Barkhof F, et al: White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol 29: 1498-1504, 2008
102. Yamamoto A, Miki Y, Tomimoto H, Kanagaki M, Takahashi T, et al: Age-related signal intensity changes in the corpus callosum: assessment with three orthogonal FLAIR images. Eur Radiol 15: 2304-2311, 2005 (Pubitemid 41600115)
103. Sachdev P, Wen W, Chen X, Brodaty H: Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 68: 214-222, 2007 (Pubitemid 46105740)
104. Austrian Stroke Prevention Study; Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F, et al: Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 361: 2046-2048, 2003
105. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP: MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology 53: 132-139, 1999 (Pubitemid 29329661)
106. Yamada K, Sakai K, Owada K, Mineura K, Nishimura T: Cerebral white matter lesions may be partially reversible in patients with carotid artery stenosis. AJNR Am J Neuroradiol 31: 1350-1352, 2010
107. Della Nave R, Foresti S, Pratesi A, Ginestroni A, Inzitari M, et al: Whole-brain histogram and voxel-based analyses of diffusion tensor imaging in patients with leukoaraiosis: correlation with motor and cognitive impairment. AJNR Am J Neuroradiol 28: 1313-1319, 2007 (Pubitemid 47309665)
108. Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, et al: MTI of white matter hyperintensities. Brain 128: 2926-2932, 2005 (Pubitemid 41746645)
109. Rosano C, Sigurdsson S, Siggeirsdottir K, Phillips CL, Garcia M, et al: Magnetization transfer imaging, white matter hyperintensities, brain atrophy and slower gait in older men and women. Neurobiol Aging 31: 1197-1204, 2010
110. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, et al: Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 57: 2307-2310, 2001 (Pubitemid 34016470)
111. Mori N, Miki Y, Fushimi Y, Kikuta K, Urayama S, et al: Cerebral infarction associated with moyamoya disease: histogram-based quantitative analysis of diffusion tensor imaging: a preliminary study. Magn Reson Imaging 26: 835-840, 2008
112. 2 prep three-dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 tesla. Magn Reson Med 67: 614-621, 2012
113. Theysohn JM, Kraff O, Maderwald S, Barth M, Ladd SC, et al: 7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J Magn Reson Imaging 33: 782-791, 2011